首页> 外文期刊>Blood: The Journal of the American Society of Hematology >A cluster of mutations in the D3 domain of von Willebrand factor correlates with a distinct subgroup of von Willebrand disease: type 2A/IIE.
【24h】

A cluster of mutations in the D3 domain of von Willebrand factor correlates with a distinct subgroup of von Willebrand disease: type 2A/IIE.

机译:von Willebrand因子的D3结构域中的一簇突变与von Willebrand疾病的一个独特亚群相关:2A / IIE型。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Among the different phenotypes of von Willebrand disease (VWD) type 2A, we identified a particular subgroup with a high frequency of 29%, characterized by a relative decrease of large von Willebrand factor (VWF) multimers and decreased A Disintegrin And Metalloproteinase with ThromboSpondin type 1 motifs, member 13 (ADAMTS13)-mediated proteolysis previously described in a single family as VWD type IIE (VWD2A/IIE). Phenotype and genotype of 57 patients from 38 unrelated families displaying a particular multimer pattern resembling the original VWD2A/IIE were studied. Pathogenicity of candidate mutations was confirmed by expression studies and phenotypic characterization of recombinant mutants. Specific mutations were identified in all patients. Twenty-two different mutations, most of them affecting cysteine residues, 17 of them being novel, are clustering mainly in the VWF D3 domain and correlate with the VWD2A/IIE phenotype. An intracellular retention of most mutants and/or a defect of multimerization seem to be the main pathogenic molecular mechanisms. ADAMTS13 proteolysis of mutant VWF was not different from wild-type VWF in a static assay, suggesting that reduced in vivo proteolysis is not an intrinsic property of mutant VWF. Our study identified a distinct VWD subtype with a common molecular background which contributes significantly to the heterogeneous spectrum of VWD.
机译:在2A型von Willebrand病(VWD)的不同表型中,我们鉴定出一个特定的亚组,其高频率为29%,其特征是大的von Willebrand因子(VWF)多聚体相对减少,而ThromboSpondin型的A整合素和金属蛋白酶减少1个基序,成员13(ADAMTS13)介导的蛋白水解,以前在一个家族中称为VWD IIE(VWD2A / IIE)。研究了来自38个无关家庭的57位患者的表型和基因型,这些患者表现出类似于原始VWD2A / IIE的特定多聚体模式。通过表达研究和重组突变体的表型表征证实了候选突变的致病性。在所有患者中鉴定出特定的突变。 22个不同的突变(主要影响半胱氨酸残基,其中的17个是新突变)主要聚集在VWF D3结构域中,并与VWD2A / IIE表型相关。大多数突变体的细胞内滞留和/或多聚化缺陷似乎是主要的致病分子机制。在静态测定中,突变型VWF的ADAMTS13蛋白水解与野生型VWF并无不同,这表明体内蛋白水解降低不是突变型VWF的固有特性。我们的研究确定了具有共同分子背景的独特VWD亚型,这对VWD的异质光谱有显着贡献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号